XBIO

NASD Xenetic Biosciences, Inc.
Oct 6, 2026 · 1:29 PM ET DELAYED Market Open

$2.20 ↓ -0.00 (-0.10%) Trading Down from the previous close of $2.20, $0.14 below the day’s high of $2.34

YTD change
+1.29%
vs 20-day SMA
-25.51%
vs 200-day SMA
-23.03%

Price ranges

Previous day
$2.19 $2.29
open $2.23 close $2.20
-$0.03 (-1.35%)
Today
$2.11 $2.34
open $2.19 now $2.20
+$0.01 (+0.36%)
Past week
$2.11 $2.35
from $2.33 now $2.20
-$0.13 (-5.67%)
Past month
$1.87 $4.76
from $4.67 now $2.20
-$2.47 (-52.94%)
This year
$1.87 $4.94
from $2.17 now $2.20
+$0.03 (+1.29%)

Price & Performance

-0.95 (-30.27%) / 6M

$1.99$2.95$3.91$4.87Apr 6Jul 7Oct 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.8% away from all-time highs of $1,074.00
  • XBIO is up 1% since the beginning of the year
  • XBIO is down 32% over the past 12 months
  • XBIO is down 53% over the past 1 month
  • 1% of all XBIO investors are betting against XBIO

XBIO reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -32.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.41
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-1424160.0
Beta 2.00

Balance sheet & scale

IncomeN/A
Revenue$3.3M
Cash$6.5M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $5.1M

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $402.98 -0.01%
MRNA Moderna, Inc. $203.21 +6.95%
RVMD Revolution Medicines, Inc. $207.68 +0.50%
ROIV Roivant Sciences Ltd. $35.78 +0.17%
BNTX BioNTech SE Sponsored ADR $97.64 +0.76%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.